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ABSTRACT - Background: Disorders of water and sodium balance are frequently seen in patients with se-
vere brain injury (SBI), and may worsen their prognosis.  Purpose: To evaluate vasopressin (AVP) serum lev-
els and sodium and water balance disorders during the first week post-injury in patients with SBI.  Method:
Thirty-six adult patients with SBI (admission Glasgow Coma Scale score ≤ 8) and an estimated time of injury 
≤ 72 hours were prospectively studied. Clinical and laboratory data were recorded and AVP was measured in 
venous blood samples collected on the 1st, 2nd, 3rd and 5th days following inclusion.  Results: AVP serum lev-
els remained within the normal range in SBI patients (either traumatic or non-traumatic), although tended 
to be greater in non-survivor than in survivor patients (p=0.025 at 3rd day). In-hospital mortality was 43% 
(15/36), and serum sodium and plasma osmolality variabilities were greater in non-survivor than in survivor 
patients during the observation period (p<0.001).  Conclusion: AVP serum levels remained within the nor-
mal range values in these SBI patients, but those who died have shown higher incidence of abnormal sodi-
um and water balance during the first week post-injury.
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Níveis séricos de vasopressina e distúrbios de sódio e água em pacientes com lesão cerebral grave
RESUMO - Antecedentes: Desordens do balanço de água e sódio são frequentemente vistas em pacientes com 
lesão cerebral grave (LCG), podendo agravar o prognóstico.  Objetivo: Avaliar os níveis séricos de vasopres-
sina (AVP) e a incidência de distúrbios da água e sódio na primeira semana pós-lesão em pacientes com LCG. 
Método: Trinta e seis pacientes adultos com LCG (pontuação inicial na escala de coma de Glasgow ≤ 8) e tem-
po estimado de lesão ≤ 72h foram estudados prospectivamente. Dados laboratoriais e clínicos foram regis-
trados e os níveis séricos de AVP foram mensurados no 1o, 2o, 3o e 5o dias pós-inclusão.  Resultados: A AVP 
manteve-se dentro da faixa de normalidade nestes pacientes, mas mostrando-se proporcionalmente mais 
elevada nos pacientes que não sobreviveram (p=0,025 no 3º dia). A mortalidade intra-hospitalar foi 43% 
(15/36) e as variações do sódio e osmolalidade plasmáticos foram maiores nos pacientes que não sobrevive-
ram durante o período de observação (p<0,001).  Conclusão: Os níveis séricos de AVP mantiveram-se den-
tro da faixa de normalidade nestes pacientes com LCG, mas aqueles não sobreviventes mostraram maior in-
cidência de anormalidades do balanço de água e sódio durante a primeira semana de evolução.
PALAVRAS-CHAVE: vasopressina; lesão cerebral grave; hiponatremia; hipernatremia. 
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Patients with severe brain injury (SBI), such as trau-
matic brain injury (TBI), hemorrhagic stroke (HS), isch-
emic stroke (IS) and subarachnoid hemorrhage (SAH) 
frequently have abnormal arginine-vasopressin (AVP) 
secretion. The patho-physiological mechanisms of AVP 
secretion have not yet been clearly defi ned1. Various 
investigators have measured AVP in plasma and in 
cerebrospinal fl uid (CSF) in patients with SBI and re-
ported high levels, suggesting that increased AVP se-
cretion may contribute to increase the primary lesion 
severity2,3. Other investigators have suggested that 
AVP serum levels may affect the mechanisms of car-
diovascular regulation of cerebral edema4. In a previ-
ous study5, we compared AVP serum levels of healthy 
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individuals with those of patients with SBI or brain 
death, and found a great variation in AVP values in 
the group with SBI, but no signifi cant differences in 
mean plasma AVP levels between the three groups. A 
negative correlation between plasma osmolality and 
sodium was also found, suggesting the presence of 
syndrome of inappropriate antidiuretic hormone se-
cretion (SIADH) in SBI group. Disorders of the sodi-
um/water balance, particularly diabetes insipidus (DI) 
and SIADH, are common complications reported in 
the acute phase of SBI, either traumatic brain injury 
or stroke, and contribute to the high morbidity and 
mortality observed in these patients6,7. Moderate and 
occasionally severe hyponatremia has been reported 
in around 30% of neurosurgical patients with SAH. 
The decrease in serum sodium was progressive, lead-
ing to neurological problems, such as confusion, leth-
argy, convulsions and, fi nally, coma8.
Hyponatremia was first reported in 1950 in pa-
tients with SBI. Excessive natriuresis was observed 
and the term “cerebral salt-wasting syndrome” was 
coined9. The hypothesis of the natriuretic factor was 
not raised and, following the discovery of the antid-
iuretic hormone, SIADH was mentioned as the caus-
al mechanism of hyponatremia in patients with SBI10. 
The pathophysiology of the secretion and liberation 
of AVP and the mechanisms involved in sodium and 
water disorders in patients with acute severe brain 
lesion have not been adequately clarifi ed. In many 
studies increased levels of AVP have been found and 
it has been suggested that this increase, in the early 
stages of the injury, may be of signifi cant importance 
in the pathogenesis of cerebral edema11. 
Therefore, the objective of the present study was 
to evaluate plasma AVP levels and the incidence of so-
dium and water disorders during the fi rst week post-
injury in acute severe brain injured patients.
METHOD
The present study was carried out in the adult inten-
sive care unit of the Hospital de Clínicas, State University 
of Campinas, between January 2003 and March 2005. The 
study protocol was approved by the Institutional Research 
Ethics Committee (Protocol Ner: 211/2002), and in all cases a 
written informed consent was obtained from a surrogate 
prior to enrollment. 
Study population – Severe brain injured group was com-
posed of 36 patients, both sexes, aging ≥18 years, with ini-
tial Glasgow Coma Scale (GCS) score ≤ 8, and an estimated 
time of injury ≤ 72 hours, enrolled non-consecutively. Exclu-
sion criteria were: aging <18 years; associated major thoracic 
or abdominal trauma; sepsis; irresponsive circulatory shock; 
patients pregnant or lactating; previous history of chronic 
corticosteroids, thyroid hormone or desmopressin use, phys-
ical signs suggestive of brain death or clinical death during 
the observation period. Laboratory data of 29 healthy vol-
unteers, previously reported 5 served as control. 
Data collection – In the SBI patients, 10 mL blood sam-
ples were drawn on the 1st (D1), 2nd (D2), 3rd (D3) and 5th day 
(D5) post-inclusion for measuring AVP and serum osmolali-
ty, using a previously placed venous catheter. A 3 mL arteri-
al blood sample was also collected for gas analysis, electro-
lytes, hemoglobin, hematocrit, lactate and glucose, using a 
previously placed arterial catheter. 
An isolated urinary sample at D1 and 24 hour urinary 
samples at D2, D3 and D5 were used for sodium and osmola-
lity measurements. Blood samples (10 mL) for measurement 
of urea, creatinine and for carrying out a leukocyte count 
were collected only once (at D1). All samples were sent to 
specifi c laboratories for immediate evaluation, except the 
AVP sample. Blood gas analysis was carried out immedi-
ately following sampling in a Radiometer ABL 700 Series®.
At the time of blood sampling for AVP measurement, 
the following clinical parameters were recorded: systemic 
blood pressure (SBP), central venous pressure (CVP), heart 
rate, urinary output and body temperature.
AVP measurement was carried out at the Laboratory of 
Endocrine Physiology, Ribeirão Preto School of Medicine, 
University of São Paulo, as previously reported5. 
During data collection, the volumes and types of fl u-
id infused into the patients in the preceding 24 hours were 
registered for calculating the quantity of sodium that has 
been administered. Simultaneously, twenty-four hour urine 
collection was carried out, stored at 4oC and sent for mea-
surement of urinary sodium. Sodium balance was then cal-
culated at D2, D3 and D5.
Statistical analysis – For the purpose of statistical anal-
ysis the patients were divided into two groups: 1) patients 
with traumatic brain injury (TBI; n=20) and non-traumatic 
brain injury (NTBI; n=16); and 2) survivors (S) and non-sur-
vivors (NS). Some variables of interest were compared be-
tween groups at each time (D1; D2; D3 and D5 after enroll-
ment) as well as their respective evolutions in time within 
each group.
Samples’ profi le, according to the variables in the study, 
was carried out using frequency tables for categorical vari-
ables. Statistical analysis of continuous variables was de-
scribed by using means, standard deviation and median. 
Categorical variables between groups were evaluated by 
using Chi-squared test or, when indicated, Fisher’s exact 
test. To compare the basal characteristics between groups 
(NTBI and TBI), simple analysis of variance was used (one-
way ANOVA). Multiple comparisons were performed using 
Tukey’s post-hoc test. To analyze the relationship between 
numerical variables, Spearman’s correlation coeffi cient was 
used. To study the relationship between variables of inter-
est and the longitudinal levels of AVP, generalized estima-
tion equations were used.
To analyze and compare the evolution of measured 
variables between two groups at the four times of sam-
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pling, analysis of variance (ANOVA) for repeated measures 
was used. Comparisons between groups were made using 
Tukey’s post-hoc test and comparison between times was 
made using the profi le contrast test. Since there was no nor-
mal distribution, variables were transformed into ranks or 
posts. The Mann-Whitney test was used to compare values 
between groups.
Differences were considered signifi cant if p<0.05. 
RESULTS
Demographic and initial (D1) clinical and labora-
tory data from patients are shown in Table 1. No dif-
ferences were found between them. AVP mean val-
ues of both groups were inside the normal range pre-
viously reported in normal volunteers5.
More neurosurgical procedures were carried out 
in NTBI than in TBI patients [15/17 (88%) vs 8/19 (42%), 
respectively; p=0.006]. The values of some variables 
of interest during observation time (D1 to D5) in TBI 
and NTBI patients are shown in Table 2. Serum AVP 
levels remained inside the normal range, tending to 
decrease along the fi rst week post-injury (p=0.059), 
without differences between groups (Table 2). Addi-
tionally, in NTBI patients, sodium balance at D2 was 
more positive than that of D3 (p=0.019), but no sig-
nifi cant differences were found in comparison to TBI 
patients at any time.
Total in-hospital mortality of SBI patients was 42% 
(15/36 patients), and there was no signifi cant differ-
ence in mortality between NTBI and TBI groups [8/17 
(47%) vs 7/19 (41%), respectively; p=0.535]. Neuro-
logical related death was found in 9/15 (60%) pa-
tients and occurred early (median 8,3 days post-in-
jury) and non-neurological related death was found 
in 6/15 (40%) patients (pneumonia/acute respiratory 
failure: 2 patients; ARDS: 1 patient; MODS: 2 patients 
and barotrauma: 1 patient) and occurred later (medi-
an 42 days post-injury).
Survivor and non-survivor patients were compa-
rable in relation to age, initial GCS score and time 
from injury to inclusion in the protocol. These data 
and the values of some variables of interest during 
the observation period in survivor and non-survivor 
patients are shown in Table 3. Its of note that larg-
er fl uctuations of serum sodium levels away from the 
normal range were more frequently seen in non-sur-
vivors than in survivors during the observation time 
(p<0.001 at D1, D2 e D4). These data are better ap-
preciated in Figure 1. Serum osmolality variability 
was also higher in non-survivors than in non-survi-
vors during the observation time (p=0.009 at D2, D3 
and D5). Oxygenation index (PAO2/FiO2) has shown 
lower values in patients who died in relation to survi-
Table 1. Demographic and initial characteristics (D1) of patients with severe traumatic (TBI) and non-
traumatic brain injury (NTBI).
Characteristics TBI (n=19) NTBI (n=17) p-value
Age (years) 33 (10) [31] 41 (15) [37] 0.123
Sex (male/female) 17 / 2 14 / 3 0.650 NS
Time from injury (hours) 40 (12) [38] 36(15) [36] 0.655  
Admission GCS score 5.4 (2.0) [5] 5.2 (2.0) [6] 0.604
Mean arterial pressure (mmHg) 98 (14) [94] 104 (16) [104] 0.091
Heart rate (bpm) 94 (15) [95] 86 (22) [82] 0.076
Central venous pressure (cmH2O) 13 (5) [12] 11 (4) [10] 0.269
Axillary temperature (ºC) 37.2 (0.8) [37.4] 36.9 (0.8) [37.0] 0.059
PaO2/FiO2 (mmHg) 294 (70) [312] 278 (119) [267] 0.623
Leukocyte count (103.cells/mm3) 13.3 (7.1) [11] 14.2 (5.9) [12.9] 0.311
Hematocrit (%) 29 (6) [27] 33 (5) [32] 0.472
Creatinine (mg%) 0.77 (0.25) [0.75] 0.86 (0.33) [0.85] 0.401
Serum sodium (mEq/L) 141 (8) [139] 139 (5) [138] 0.867
Serum potassium (mEq/L) 3.8 (0.4) [3.7] 3.7 (0.7) [3.6] 0.203
Glicemia (mg%) 140 (29) [136] 172 (59) [153] 0.067
Serum lactate (mMol/L) 1.8 (0.8) [1.5] 2.3 (1.2) [2.0] 0.591
Serum osmolality (mOsm/L) 300 (16) [296] 299 (12) [296] 0.696
Serum vasopressin (pg/mL) 2.4 (3.8) [1.3] 2.2 (1.4) [2.0] 0.533
Urinary sodium (mEq/L) 102 (73) [80] 107 (78) [75] 0.873
Urinary osmolality (mOsm/L) 406 (191) [380] 483 (248) [497] 0.224
Values are expressed as mean (± standard deviation) [median]
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Table 2. Evolution of some variables of interest during the ob-
servation period in patients with severe traumatic (TBI) and 
non-traumatic brain injury (NTBI).
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Values are expressed as mean (± standard deviation) [median]. (a)D2 ≠ 
D3 in NTBI.
Table 3. Demographic, basal characteristics and some variables 
of interest and their evolution during the observation period 
in survivor (S) and non-survivor (NS) patients.
Variables Survivors (n=21) Non-survivors (n=15) p-value
Age (years) 38 (15) [35] 35 (11) [33] 0.772
Sex (M/F) 19/2 12/3 0.63
Admission 
GCS score 
5.5 (2.1) [6] 5.1 (2.0) [5] 0.588
Time from
injury (hours)
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Values are expressed as mean (± standard deviation) [median]. (a)S ≠ NS 
at D5;  D5 ≠ D1 in NS; (b)S ≠ NS at D2, D3 and D5; (c)S ≠ NS at D2; D2 ≠ D1 in 
NS; (d)S ≠ NS at D3; (e)S ≠ NS at D3; (f)S ≠ NS at D5.
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vors (p<0.001 at D5). Serum lactate was higher in pa-
tients who did not survive compared to survivors (p= 
0.029 at D2, D3 and D5).
AVP serum levels, although ever remaining inside 
the normal range, were slightly higher in non-sur-
vivors than in survivors at D3 (p=0.025). These data 
could be better appreciated in Figure 2. 
Severe hyponatremia (serum sodium <120mEq/L) 
was not observed at any moment in this group of 
patients. Additionally, no signifi cant correlation be-
tween AVP serum levels and serum sodium or serum 
osmolality could be demonstrated.
 
DISCUSSION 
Plasma levels of AVP in healthy individuals at rest 
are usually very low. Chen et al.12 reported AVP levels 
ranging from 2.2-8.0 pg/mL in patients with normal 
volemia, normal blood pressure and serum osmolality 
≤ 290 mOsm/kg. In a study that evaluated endocrine 
failure following brain death, Gramm et al.13 used 
plasma AVP levels of 0.3-4.7 pg/mL as a reference 
value. Cintra et al.5, in normal resting adult individu-
als (control group), have reported plasma AVP levels 
of 2.22±1.15 pg/mL, varying from 0.4-5.2 pg/mL.
In the present study, mean AVP values in SBI pa-
tients were not signifi cantly different from normal 
ranges. Similar fi ndings had already been reported 
in a previous study carried out by the same authors, 
in which AVP serum levels in patients with SBI, de-
spite of some individual variation expressed by plas-
matic peaks, were comparable to those of the control 
group5. On the other hand, high serum AVP levels 
were found by Tenedieva et al.4 in patients with cere-
bral edema. These investigators reported that this al-
teration is related to the regulation of cardiovascular 
mechanisms and the development of cerebral edema. 
In a study to evaluate AVP levels in SBI, other investi-
gators3 have suggested that the increase in intracra-
nial pressure stimulates central vasopressin release.
Multiple endocrine abnormalities have been 
reported in patients with SBI, particularly second-
ary to stroke, and some of them play an important 
role in aggravating the neurological defi cit. Various 
pathophysiological mechanisms have been proposed 
to explain these alterations, including the direct ef-
fect of neuronal death, vasospasm and cerebral 
edema. Apparently, AVP plays an important role 
in the pathogenesis of these alterations following 
a stroke8,14. However, the hypothesis that high AVP 
levels must be related to an increase in morbidity and 
mortality in patients with SBI couldn’t be supported 
in our study. On the contrary, our data have shown 
that AVP serum levels always remained within the 
normal range in survivor and non-survivor patients. 
Diabetes insipidus – Disorders of sodium and wa-
ter balance are the most well-known complications 
in the acute phase of SBI, especially traumatic one, 
Fig 1. Fluctuations of serum sodium levels in survivors and non-survivors.
Fig 2. Vasopressin serum levels in survivors and non-survivors.
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contributing towards an increase in early morbidity 
observed in these patients6. Many cases of DI in this 
acute phase are considered transitory, and permanent 
DI following TBI has been rarely reported15,16. Never-
theless, patients with a partial AVP defi cit may be eas-
ily confounded, since symptoms are mild and the clini-
cal course of the post-traumatic injury is frequently 
complicated by signifi cant alterations in cognitive and 
neurological abilities16-19. 
Post-traumatic DI may result from an infl ammato-
ry edema around the neurons of the hypothalamus or 
posterior pituitary that may recover following resolu-
tion of the swelling. This may also be a result of dam-
age to the hypothalamic neurons in the supraoptic 
and paraventricular regions or in the terminal axons 
of the posterior pituitary. These abnormalities may be 
transient when the neurons make new connections 
or may be permanent if gliosis occurs15.
Little research has been carried out in the pos-
terior pituitary function of survivors of TBI. Agha et 
al.16 reported a signifi cant functional alteration in the 
gland, both in the early and later stages, suggesting 
that the treatment of these abnormalities is of vital 
importance in maximizing the potential for recupera-
tion of these patients and reducing morbidity. Wong 
et al.20 reported the occurrence of DI in 3.7% of neu-
rosurgical patients in an intensive care unit. In a ret-
rospective study, Boughey et al.21 reported that the in-
cidence of DI in patients with TBI was 2.9%. However, 
these investigators excluded patients with incomplete 
data for diagnosis from the study, but failed to re-
late how many patients were excluded. Mean plasma 
sodium level in their study was 161 mEq/L, suggest-
ing that their patients were very critically ill21. More-
over, in this same study, moderate manifestations of 
DI were also confounded, since urine hypotonicity 
was defi ned at an arbitrary borderline value of 300 
mOsmol/kg. In our study, serum sodium and plasma 
osmolality tended to be higher in non-survivor pa-
tients, confi rming the observation that high plasma 
levels of sodium are strongly related to injury severity. 
However, in normal individuals, when plasma levels 
of sodium exceed 145mEq/L, there is an increase in 
AVP secretion, resulting in a maximum urinary con-
centration22. Therefore, urinary osmolality between 
300-600 mOsmol/kg in a hypernatremic patient may 
be inappropriately low and consistent with a diag-
nosis of DI22.
The routine application of plasma AVP measure-
ment in clinical practice, although feasible, has se-
rious limitations due to the technical complexities 
involved, and the results must be interpreted with 
caution because its secretion is stimulated by stress, 
intracranial hypertension, pain, opioid drugs use, etc, 
factors that are frequently present in patients with 
severe neurological lesions10.
In the present study, AVP plasma levels tended to 
fall between D1 (0-72 hours post-injury) and D5 (72-
144 hours post-injury), although not statistically signif-
icant. Higher values were seen at D1, i.e., at the most 
acute phase of brain injury, the moment at which its 
liberation may be stimulated by stress and/or intrac-
ranial hypertension. The initially normal levels at D1 
and a subsequent fall in plasma AVP at D5 observed 
in this study point to the fact that these alterations 
have to be evaluated earlier (immediately following 
the causal event) and for a longer period following 
acute brain injury, as suggested by many authors16-19.
Syndrome of inappropriate antidiuretic hormone 
secretion – Studies on the prevalence of SIADH in 
post-TBI patients have resulted in confl icting data, 
with the incidence varying from 2.3% to 36.6% 10,23,24, 
refl ecting different selection of diagnostic criteria 
for the patients studied. SIADH is caused by the un-
controlled release of AVP, resulting from damage to 
the posterior hypothalamic-pituitary axis10,23-25. Rec-
ognition and treatment of acute hyponatremia is of 
vital importance, since in hospitalized patients this 
disorder is associated with high morbidity and mortal-
ity26. This is highly relevant in patients with SBI, since 
hyponatremia increases the risk of cerebral edema, 
which exacerbates the primary neurological injury 
and increases the risk of convulsions. In the present 
study, non-survivor patients have shown greater de-
viations from normal levels of serum sodium than 
the survivors, which is in agreement with fi ndings in 
the literature that patients with signifi cant altera-
tions of serum sodium (hypo- or hypernatremia) may 
have more severe brain lesions and higher mortal-
ity rates27. However, none of our patients has shown 
severe hiponatremia or highly abnormal serum AVP 
levels during the observation time (fi ve days), thus 
precluding the possibility of diagnosing SIADH. 
In patients with intracranial hemorrhage and hy-
ponatremia, high levels of AVP were reported in re-
lation to a relative low plasma osmolality1. In other 
studies, AVP levels in patients with SAH decreased 
after remaining high for two days, and many of these 
patients did not develop hyponatremia until the end 
of the fi rst week28. In a study carried out in 298 pa-
tients with SAH, the patients developed both hyper-
natremia and hyponatremia; however, hypernatremia 
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was associated with more severe brain lesions and 
higher mortality rates. Nevertheless, the investigators 
suggested that further studies should be carried out 
to determine the underlying mechanism present in 
this hypernatremia27.
Cerebral salt-wasting syndrome (CSWS) – Cerebral 
salt-wasting syndrome has been proposed as an alter-
native for explanation of hyponatremia in patients 
with intracranial disorders. In this syndrome, primary 
natriuresis leads to a negative sodium balance and re-
duction in extracellular volume. To correct the circu-
lating volume, the regulators of plasma volume, i.e.: 
the renin-angiotensin-aldosterone system, the sympa-
thetic nervous system and the AVP secretion, are ac-
tivated. Indeed, despite hypo-osmolality, vasopressin 
secretion is not suppressed in patients with hypona-
tremia following intracranial bleeding or SAH1,8,28. This 
“inappropriate” AVP secretion is, in fact, appropriate 
with respect to the reduction in circulatory volume 
and, consequently, the regulation of volume prevails 
over osmoregulation. In practice, it is very important 
to determine the cause of hyponatremia in patients 
with intracranial disorders, and CSWS should be clear-
ly differentiated from SIADH since their management 
principles are virtually opposites10.
However, the pathophysiology of CSWS is still con-
troversial. Some authors have reported that increased 
atrial natriuretic peptide (ANP) may cause hypona-
tremia28-30. Sviri et al.30 reported that brain natriuretic 
peptide (BNP) levels increases shortly after head in-
jury and remains continuously elevated during the 
acute phase in patients with extensive SAH and in 
those with high intracranial pressure (ICP), showing 
a positive correlation with poor outcomes. 
The literature emphasizes the fact that the in-
crease in the permeability of the cerebral capillaries 
is one of the most important mechanisms responsible 
for the maintenance of cerebral edema in patients 
with SBI and that the alterations in sodium and AVP 
may contribute greatly to the maintenance of this 
homeostasis16,24.
There is relevant evidence in the literature that 
sodium and water disturbances associated with SBI 
may aggravate primary brain lesion and lead to irre-
versible neuronal damage10,16,24. Nevertheless, much 
remains undefi ned with respect to the differentia-
tion of the syndromes involving these disturbances, 
particularly between SIADH and CSWS. There is a 
consensus in the literature that investigations on this 
subject should seek to achieve early recognition of 
these alterations and subsequent prevention of the 
disturbances that may lead to deterioration of the 
brain lesion6,10,16,24.
In the present study, patients with severe brain 
lesions (traumatic or not) presenting greater serum 
sodium deviations from the normal range during the 
observation period have shown higher mortality rates. 
Respiratory and metabolic disturbances – Acute 
neurogenic pulmonary edema, a common and under-
diagnosed complication, can occur after virtually any 
form of injury to the central nervous system and is a 
potential early contributor to pulmonary dysfunction 
in patients with head injury. Bahloul et al.31 evaluated 
myocardial function in patients with evident neuro-
genic pulmonary edema after TBI, and found that ev-
ery patient with neurogenic pulmonary edema also 
had myocardial dysfunction. The mechanisms respon-
sible for myocardial dysfunction were multiple, and 
the investigators suggested that further studies are 
needed to adequately understand the pathophysiol-
ogy of this pulmonary and cardiac dysfunction. 
Wu et al.32 suggested that increased intracranial 
pressure secondary to brain hemorrhage may pro-
mote localized activation of cytokines and coagula-
tion system, including tissue factors release. However, 
whether intracerebral hemorrhage triggers infl amma-
tion in noncerebral organs has not been elucidated.
In our patients, some degree of acute pulmonary 
dysfunction has been observed, expressed by a fall in 
PaO2/FiO2 relationship, but no overt pulmonary failure 
(either pulmonary edema or acute respiratory distress 
syndrome) has been recorded. A progressive deterio-
ration of pulmonary function was seen in non-survi-
vor from D1 to D5, but this could only be a refl ex of a 
more severe brain lesion in these patients. 
In SBI patients altered cell metabolism is described, 
and this fact has been attributed to neurohormonal 
abnormalities secondary to hypothalamic-hypophy-
seal dysfunction33. Recent experimental studies have 
demonstrated that some degree of brain mitochon-
drial dysfunction occurs early in acute traumatic brain 
injury and could play an important role in post-injury 
neuronal abnormalities34,35. Some investigators hy-
pothesize that mitochondrial oxidative damage and 
dysfunction precede the onset of neuronal loss after 
controlled cortical impact traumatic brain injury, and 
suggest that future studies directed at reversing mito-
chondrial abnormalities could guide neuroprotective 
interventions after TBI35.
Increased anaerobic metabolism and acid-base 
and electrolyte abnormalities are frequently seen in 
severe brain injured patients the consequences of this 
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derangement33. Indeed, in the present study, patients 
with severe brain lesions (traumatic or not), especially 
those who died, have shown increased serum lactate 
levels and great serum sodium deviations from the 
normal range during the observation period. So, it is 
important to emphasize the need for a strictly moni-
toring of hydroelectrolytic, acid-base and metabolic 
status during the evolution of SBI patients and at-
tempting to clearly defi ne the cause of these altera-
tions, with the objective of proposing therapeutic 
measures to minimize the risk of aggravating the pri-
mary brain lesion and the morbidity-mortality rates. 
In conclusion, there was a slight variability of 
serum AVP levels in patients with SBI, seen as iso-
lated plasmatic peaks, but their mean values always 
remained within the normal range, and these levels 
tended to decrease over time, both in survivors and 
non-survivors. Serum sodium and plasma osmolality 
have shown great variations in patients with SBI, and 
non-survivors have shown greater and more signifi -
cant deviations from normal values than those who 
survived. These data permit us to conclude that pa-
tients with SBI have relatively frequent and serious 
disorders of sodium and water balance during their 
evolution in the acute phase, and the greater these 
alterations, the greater the mortality rates. Neverthe-
less, these results do not allow us to make a clear 
differentiation between the different syndromes in-
volved in sodium and water disturbances in patients 
with SBI, suggesting that they need to be studied at 
an earlier stage and for longer periods to enable bet-
ter characterization and differentiation of these al-
terations, as well as to defi ne more clearly whether 
these disturbances aggravate the primary brain lesion 
or if they are merely a refl ex of injury severity.
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